Not really, created a gap in NEM's chart early on. It was good thing to go back, and to fill the gap, which it did. Gaps represent underlying weakness.
Where does your family prefer your body be shipped to. I might suggest that they donate your organs, and they can additionally claim that your brain has never been used.
Lightest volume of the week, as it continues to build a base. MACD is declining but, way more important is the fact that the stock's 50 dma has surged through it's 200 dma. All good. MACD can continue to decline as the stock continues it's base building.
It figures your week consists of only one day.
"Nothing in the world is more dangerous than sincere ignorance and conscientious stupidity."
Martin Luther King, Jr.
And wait until next week, it's going to look gorgeous.
And on a decidedly weak performance of the market, NBIX is holding very nicely. Shorts are getting desperate, aren't they? Love it!
Stay short by all means, as Einstein related "There are only two things that are infinite, the universe and human stupidity, and I'm not sure about the former."
And you would plainly see that NBIX created a huge, huge breakaway gap, going back to the exact point where it reported the results of it's first Phase II on NBI-98854 last September, and it's subsequent gap down.
Most islands, huh? You are in deep do-do, and will lose your shirt.
beginning to look healthy. In another 2 weeks, it will look even more healthy, causing those who shorted the stock to have second thoughts, as to why they ever got involved in the first place. Far be it from me to call the short sellers stupid.
"I have many regrets, and I'm sure everyone does. The stupid things you do. you regret ,,, if you have any sense, and if you don't regret them, maybe you're stupid."
A good CEO would normally minimize the potential on a blockbuster new drug, that doesn't have any competitors. Tardive has been around for decades, and there has been absolutely nothing produced in a drug to mollify the tardive ---- zero, zip, nada, nothing has worked. If you worked in the medical/psychiatric field, you would know this, and would recognize what this means, and understand where NBIX is going. This is life-changing for patients suffering from tardive.
Gets put on FDA Fast Track, and you'll be dreading the day you ever sold.
The had been no effective treatment for people who suffer from tardive dyskinesia. So this announcement is potentially huge, and the drug is not even on the market yet.
People who suffer from tardive dyskinesia are highly aware of their appearance, and so too are their families, and the medical staff that work with these patients. Anything that can significantly reduce the effects of tardive on patients, provided it is proven safe, will be highly, highly sought out, simply because there is nothing in the marketplace that does currently.
If you're holding this stock, Congratulations!!! You have a winner. If you're short the stock, you have a problem.
You read whatever you want to read in terms of your technical analysis books. You can believe me when I comment, or dis-believe, I couldn't care less. I gave you a very detailed explanation as to why the gap would be filled at 196, that I said it would do so weeks and weeks ago. I suggest that maybe you're not as smart as you think you are. This is laughable. The stock is down over 60 points, and is very close to filling the gap, that I said it would fill, and you're still in denial. Absolute silliness!!!
I posed the issue, even longer ago, when I said that ATRI would fill another of it's gaps. Some didn't believe me, or didn't think it would do so compared to where the stock had moved off to but, it eventually did. I remarked back then that ATRI tends to fill all of it's gaps, as it should. I'll even share a conspiracy theory with you, that is fact based on a heavy dose of reality of trading this little gem of a company, which may also explain why the occur, and why they're destined to be filled. ATRI stock is highly illiquid. You know that, and I know that. But, the market makers in the stock are all too knowing, also. Since market makers thrive on stock trading activity - both, the buying as well as the selling of shares, it is in their absolute best interest if they can assist in creating the proper environment for it to occur. Because, they make money on activity, which for all intents and purposes is not just buys. So, in an illiquid stock like ATRI, don't you think it would behoove a market maker(s) to "assist" in creating that gap, knowing full well, that at some point in the near future, there would be pressure exerted to fill the underlying weakness (the gap), that they knowingly helped to create. It all insures that they make money. Anytime one sees a gap created in the trading of a stock, one needs to be fully aware of it, and ask themselves, "What just happened?" and "What really is going on?" The obvious isn't really always so obvious, is it?